Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360999750> ?p ?o ?g. }
- W4360999750 endingPage "e068943" @default.
- W4360999750 startingPage "e068943" @default.
- W4360999750 abstract "Rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone, once every 3 weeks (R-CHOP21) is commonly used in non-Hodgkin's lymphoma (NHL), but accompanied by Pneumocystis carinii pneumonia (PCP) as a fatal treatment complication. This study aims to estimate the specific effectiveness and cost-effectiveness of PCP prophylaxis in NHL undergoing R-CHOP21.A two-part decision analytical model was developed. Prevention effects were determined by systemic review of PubMed, Embase, Cochrane Library and Web of Science from inception to December 2022. Studies reporting results of PCP prophylaxis were included. Enrolled studies were quality assessed with Newcastle-Ottawa Scale. Costs were derived from the Chinese official websites, and clinical outcomes and utilities were obtained from published literature. Uncertainty was evaluated through deterministic and probabilistic sensitivity analyses (DSA and PSA). Willingness-to-pay (WTP) threshold was set as US$31 315.23/quality-adjusted life year (QALY) (threefold the 2021 per capita Chinese gross domestic product).Chinese healthcare system perspective.NHL receiving R-CHOP21.PCP prophylaxis versus no prophylaxis.Prevention effects were pooled as relative risk (RR) with 95% CI. QALYs and incremental cost-effectiveness ratio (ICER) were calculated.A total of four retrospective cohort studies with 1796 participants were included. PCP risk was inversely associated with prophylaxis in NHL receiving R-CHOP21 (RR 0.17; 95% CI 0.04 to 0.67; p=0.01). Compared with no prophylaxis, PCP prophylaxis would incur an additional cost of US$527.61, and 0.57 QALYs gained, which yielded an ICER of US$929.25/QALY. DSA indicated that model results were most sensitive to the risk of PCP and preventive effectiveness. In PSA, the probability that prophylaxis was cost-effective at the WTP threshold was 100%.Prophylaxis for PCP in NHL receiving R-CHOP21 is highly effective from retrospective studies, and routine chemoprophylaxis against PCP is overwhelmingly cost-effective from Chinese healthcare system perspective. Large sample size and prospective controlled studies are warranted." @default.
- W4360999750 created "2023-03-30" @default.
- W4360999750 creator A5005196775 @default.
- W4360999750 creator A5006706475 @default.
- W4360999750 creator A5006756737 @default.
- W4360999750 creator A5017453632 @default.
- W4360999750 creator A5020232250 @default.
- W4360999750 creator A5022568174 @default.
- W4360999750 creator A5031465004 @default.
- W4360999750 creator A5033096447 @default.
- W4360999750 creator A5040548754 @default.
- W4360999750 creator A5072285204 @default.
- W4360999750 creator A5082951115 @default.
- W4360999750 date "2023-03-01" @default.
- W4360999750 modified "2023-09-26" @default.
- W4360999750 title "Prophylaxis for<i>Pneumocystis carinii</i>pneumonia in non-Hodgkin’s lymphoma undergoing R-CHOP21 in China: a meta-analysis and cost-effectiveness analysis" @default.
- W4360999750 cites W1979239212 @default.
- W4360999750 cites W1987889643 @default.
- W4360999750 cites W2003835506 @default.
- W4360999750 cites W2008003134 @default.
- W4360999750 cites W2008795105 @default.
- W4360999750 cites W2009191095 @default.
- W4360999750 cites W2012216695 @default.
- W4360999750 cites W2022187773 @default.
- W4360999750 cites W2058015212 @default.
- W4360999750 cites W2068171001 @default.
- W4360999750 cites W2072138215 @default.
- W4360999750 cites W2076257589 @default.
- W4360999750 cites W2081604198 @default.
- W4360999750 cites W2095621848 @default.
- W4360999750 cites W2125435699 @default.
- W4360999750 cites W2126234152 @default.
- W4360999750 cites W2129246503 @default.
- W4360999750 cites W2135152649 @default.
- W4360999750 cites W2169605843 @default.
- W4360999750 cites W2296800272 @default.
- W4360999750 cites W2351199759 @default.
- W4360999750 cites W2384346244 @default.
- W4360999750 cites W2560692010 @default.
- W4360999750 cites W2606484559 @default.
- W4360999750 cites W2806495786 @default.
- W4360999750 cites W2895403217 @default.
- W4360999750 cites W2911685734 @default.
- W4360999750 cites W2912798099 @default.
- W4360999750 cites W2944604777 @default.
- W4360999750 cites W2949387169 @default.
- W4360999750 cites W2989640927 @default.
- W4360999750 cites W2999087180 @default.
- W4360999750 cites W3009740885 @default.
- W4360999750 cites W3015052232 @default.
- W4360999750 cites W3083459583 @default.
- W4360999750 cites W3086628730 @default.
- W4360999750 cites W3088448654 @default.
- W4360999750 cites W3101340434 @default.
- W4360999750 cites W3113781210 @default.
- W4360999750 cites W3128646645 @default.
- W4360999750 cites W3128918211 @default.
- W4360999750 cites W3130397143 @default.
- W4360999750 cites W3133955595 @default.
- W4360999750 cites W3137776036 @default.
- W4360999750 cites W3202306154 @default.
- W4360999750 cites W3202548806 @default.
- W4360999750 cites W3212086772 @default.
- W4360999750 cites W3212291881 @default.
- W4360999750 cites W4245401508 @default.
- W4360999750 cites W878205423 @default.
- W4360999750 doi "https://doi.org/10.1136/bmjopen-2022-068943" @default.
- W4360999750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36972963" @default.
- W4360999750 hasPublicationYear "2023" @default.
- W4360999750 type Work @default.
- W4360999750 citedByCount "0" @default.
- W4360999750 crossrefType "journal-article" @default.
- W4360999750 hasAuthorship W4360999750A5005196775 @default.
- W4360999750 hasAuthorship W4360999750A5006706475 @default.
- W4360999750 hasAuthorship W4360999750A5006756737 @default.
- W4360999750 hasAuthorship W4360999750A5017453632 @default.
- W4360999750 hasAuthorship W4360999750A5020232250 @default.
- W4360999750 hasAuthorship W4360999750A5022568174 @default.
- W4360999750 hasAuthorship W4360999750A5031465004 @default.
- W4360999750 hasAuthorship W4360999750A5033096447 @default.
- W4360999750 hasAuthorship W4360999750A5040548754 @default.
- W4360999750 hasAuthorship W4360999750A5072285204 @default.
- W4360999750 hasAuthorship W4360999750A5082951115 @default.
- W4360999750 hasBestOaLocation W43609997501 @default.
- W4360999750 hasConcept C112930515 @default.
- W4360999750 hasConcept C126322002 @default.
- W4360999750 hasConcept C2778720950 @default.
- W4360999750 hasConcept C2779338263 @default.
- W4360999750 hasConcept C2780653079 @default.
- W4360999750 hasConcept C3019080777 @default.
- W4360999750 hasConcept C44249647 @default.
- W4360999750 hasConcept C64332521 @default.
- W4360999750 hasConcept C71924100 @default.
- W4360999750 hasConcept C82789193 @default.
- W4360999750 hasConcept C95190672 @default.
- W4360999750 hasConceptScore W4360999750C112930515 @default.
- W4360999750 hasConceptScore W4360999750C126322002 @default.
- W4360999750 hasConceptScore W4360999750C2778720950 @default.